Merck & Company Inc. (MRK) Fundamentals

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.
SHARE INFORMATION
Market Cap$ 235,507,611,978
Shares Outstanding2,528,805,025
Float2,527,319,236
Percent Float99.94%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 2.64
Latest Fiscal Revenue$ 50,157,000,000
Latest Fiscal EPS$ 5.14
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 7.86
Dividend (5 Years)$ 7.89
Ex Dividend Date2022-06-14
Dividend Rate$ 2.76
Dividend Yield2.96%
Payment CashCash
HOLDERS
Institutions4,820
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months137,760,432
Institutional Holdings Percent148.4%
Institutional Sold Previous 3 Months291,586,068
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months757,524
Insider Holdings Percent0.1
Insider Sold Previous 3 Months24,653
Insider Shares Owned3,673,769
TRADING INFO
52 Week High$ 94.92
52 Week Low$ 70.89
52 Week High Change$ 26.35
21 Day Moving Average$ 88.745
21 Day Extended Moving Average$ 88.9242
50 Day Moving Average$ 88.2727
50 Day Extended Moving Average$ 87.98
200 Day Moving Average$ 80.0789
200 Day Extended Moving Average$ 82.8447
10 Day Average Volume15,298,629
20 Day Average Volume13,384,594
30 Day Average Volume12,952,504
50 Day Average Volume12,522,561
Alpha0.006455
Beta0.3591
Standard Deviation0.058310
R20.085028
7 Day Price Change$ 8.51
7 Day Percent Change10.06%
21 Day Price Change$ 3.95
21 Day Percent Change4.43%
30 Day Price Change$ -0.74171
30 Day Percent Change-0.79%
Month to Date Price Change$ 1.85
Month to Date Percent Change2.02%
Quarter to Date Price Change$ 11.75
Quarter to Date Percent Change14.43%
180 Day Price Change$ 18.68
180 Day Percent Change25.09%
200 Day Price Change$ 21.63
200 Day Percent Change30.25%
Year to Date Price Change$ 17.78
Year to Date Percent Change23.6%

Merck & Company Inc. (MRK) Key Ratios

PROFITABILITY
EBIT Margin30.8%
EBITDA Margin37.1%
Pre-Tax Profit Margin13.6%
Profit Margin Count25.87%
Gross Margin70.7%
Profit Margin TOT25.87%
INCOME STATEMENTS
Revenue$ 53,978,000,000
Revenue Per Share$ 21.3453
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-69.30
Total Debt To Equity0.80
Int Coverage19.60
Current Ratio1.40
Leverage Ratio2.70
Quick Ratio0.80
Long Term Debt To Capital0.43
VALUATION MEASURES
PE Ratio16.70
Enterprise Value$ 258,373,611,978
Price to Sales4.363
Price to Free Cash-34.50
PE High Last 5 Years87.90
Price To Book5.80
Price To Cash Flow13.80
PE Low Last 5 Years16.30
Price to Tangible Book-69.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover6.60
Invoice Turnover2.30
Assets Turnover0.60
Return Assets14.74
Return on Equity42.76
Return on Capital22.77

Merck & Company Inc. (MRK) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEORobert M. Davis
Emplyoees68000
Last AuditUQ
CIK0000310158
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2000 Galloping Hill Road
Kenilworth, NJ 7033
Websitehttps://www.merck.com
Facsimile-
Telephone+1 908 740-4000
Emailinvestor_relations@merck.com
Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220627 08:08:29